Garden State Medical Center, LLC
Garden State Medical Center, LLC was paid $15K by Medicaid between Jan 2018 and Nov 2024, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 87% of everything it billed.
33Billing provider infoGARDEN STATE MEDICAL CENTER, LLC
WHITING, NJ 08759
WHITING, NJ 08759
33aNPI1578807517assigned 11/15/2012
33bProvider typeSpecialist
28Total paid$15K
24GClaims7,199
24DCodes billed12
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Specialist providers in New Jersey
Rank by total paid#256 of 378
Median peer was paid$63K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 231 | $1K | |
| 2019 | 174 | $2K | |
| 2020 | 1,948 | $2K | |
| 2021 | 2,356 | $4K | |
| 2022 | 1,185 | $3K | |
| 2023 | 765 | $2K | |
| 2024incomplete | 540 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 87% | 3,348 | 2,946 | $13K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 676 | 620 | $2K |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | <1% | 63 | 57 | $34.14 |
| 20610 | <1% | 74 | 44 | $13.00 | |
| 80305 | <1% | 141 | 135 | $12.38 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 34 | 24 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 2,029 | 1,730 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 673 | 625 | $0.00 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 30 | 27 | $0.00 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 81 | 79 | $0.00 |
| 77002 | 0% | 30 | 13 | $0.00 | |
| G9500 | Radiation exposure indices documented in final report for procedure using fluoroscopy | 0% | 20 | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMANN, DHARAM (PROVIDER)